Chief Clinical Medical Expert at the Cell and Gene Therapy Research Center of Southern University of Science and Technology in Shenzhen of China.
Graduated from the Medical Department of Nanjing Medical University in 1982 in Nanjing, China.
From December 1982 to May 2004, worked in the Department of General Surgery at Beijing Friendship Hospital affiliated Capital Medical University in Beijing. Served as a resident physician, attending physician, and associate chief physician in the Department of General Surgery, engaged in clinical, teaching, and research work.
From August 1990 to March 1995, went to the Oncology Surgery Laboratory at Johns Hopkins University School of Medicine in USA to conduct postdoctoral research. The personal research results have been published in top international medical journals such as Circulation Journal, Journal of Clinical Investigation , Shock Journal, Surgery Journal and etc.
In May 2004, transferred to Beijing Haidian Hospital to establish the first Cancer Gene Therapy Center in China served as the center director and chief physician.
In April 2007, a comprehensive treatment center combining gene therapy, hyperthermia, and minimally invasive techniques was established at Beijing Yanhua Hospital in Beijing as the center director, chief medical expert.
From September 2015 to April 2023, served as the CEO of Beijing Ludaopei Hematology Hospital.
From March 2024 to present, Chief Clinical Medical Expert at the Cell and Gene Therapy Research Center of Southern University of Science and Technology in Shenzhen of China.
Since 2004, organized and build the medical team of the Cancer Gene Therapy Center at Beijing Haidian Hospital and Beijing Yanhua Hospital to actively explore and innovate the application of modern biological gene immune technology (P53 gene drugs, DC-CIK, NK, Car-T and other immune therapy technologies), minimally invasive surgery and non-invasive technology, traditional Chinese medicine technology, traditional surgery , radiotherapy and chemotherapy technology. Carried out multidisciplinary team (MDT) collaboration in clinical treatment, developed precise personalized technical plans to treat various types of advanced cancer patients, and formed a unique treatment concept and practice system.
Since 2004, the team has not only treated a large number of tumor patients from all over China, but also attracted nearly 1000 cancer patients from nearly 40 countries and regions, including the United States, Canada, Mexico, Panama, Germany, UK, Denmark, Sweden, Norway, Russia, Netherlands, Spain, Romania, Greece, Turkey, Singapore, Malaysia, India, Pakistan, Phlippines, Thailand, Vietnam, Hong Kong and etc. It has become a Chinese hospital department with the largest number of international cancer patients since the founding of New China.
Our achievement has received widespread attention from the international oncology community and media. Since May 2005, when the Italian newspaper “Liberty” first published a report on cancer gene therapy centers, there have been over 20 international media outlets, such as the top global media outlets “Associated Press”, “Business Week”, “Washington Post”, “CBS”, “Red Herring”. The world’s mainstream media, such as German Economic Weekly, Canadian National Television CTV, British Television 4, German Television 2, Swedish National Television, Danish National Television, Norwegian Television, Turkey National Television, and Korean National Television, have all made extensive positive reports on the tumor gene therapy center of Beijing Haidian Hospital and Beijing Yanhua Hospital from different perspectives, which has won the honor for Chinese hospitals in the world.
Dr. Li Dinggang holds positions in some domestic and international professional schools/associations:
- Member of Johns Hopkins Internal and Surgucal Society
- Honorary President of the Macao Anti Cancer Charity Association in China
- Executive Vice Chairman of the International Medical Tourism Branch of the China Healthcare International Exchange Promotion Association
- Executive Director of the International Cryosurgery Association
- Director of the Chinese Society of Cryotherapy
- Director of China Pharmaceutical Biotechnology Association
- Member of the Gene Therapy Branch of the China Medical Biotechnology Association
- Executive Committee Member of Hospital Management Branch of China Association of Non Public Medical Institutions
- Secretary General of the Cancer Prevention and Treatment Professional Committee of the Chinese National Health Association
- Member of the General Surgery Society of the Beijing Branch of the Chinese Medical Association
- Specially appointed expert of China Life Science Research and Development Foundation
- Specially appointed experts of Cancer Prevention and Control Expert Guidance Committee of Hainan Province, China , etc